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Accepted 17 February 2014; Published online 24 April 2014AbstractObjective: To compare the performance of the bias-adjusted meta-analysis to the conventional meta-analysis assessing seasonal influ-
enza vaccine effectiveness among community-dwelling elderly aged 60 years and older.
Study Design and Setting: Systematic literature search revealed 14 cohort studies that met inclusion and exclusion criteria.
Laboratory-confirmed influenza, influenza-like illness, hospitalization from influenza and/or pneumonia, and all-cause mortality were study
outcomes. Potential biases were identified using bias checklists. The magnitude and uncertainty of biases were assessed by expert opinion.
Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using random effects model.
Results: After incorporating biases, overall effect estimates regressed slightly toward no effect, with the largest relative difference be-
tween conventional and bias-adjusted ORs for laboratory-confirmed influenza (OR, 0.18; 95% CI: 0.01, 3.00 vs. OR, 0.23; 95% CI: 0.03,
2.04). In most of the studies, CIs widened reflecting uncertainties about the biases. The between-study heterogeneity reduced considerably
with the largest reduction for all-cause mortality (I2 5 4%, P 5 0.39 vs. I2 5 91%, P ! 0.01).
Conclusion: This case study showed that after addressing potential biases influenza vaccine was still estimated effective in preventing
hospitalization from influenza and/or pneumonia and all-cause mortality. Increasing the number of assessors and incorporating empirical
evidence might improve the new bias-adjustment method.  2014 The Authors. Published by Elsevier Inc.
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As seasonal influenza vaccination is standard care for old-
er adults in most of the developed countries, conducting a
randomized controlled trial (RCT) to estimate its effective-
ness would be considered unethical. Therefore, apart from
the limited number of older RCTs [1e3], the main evi-
dence about influenza vaccine effectiveness comes from* This is an open access article under the CC BY-NC-ND license
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Open access under Cobservational studies. Such studies are prone to bias because
of lack of concealed randomization and different baseline
characteristics between the vaccinated and the unvaccinated
groups [4,5]. It has been shown that confounding by indica-
tion (also known as selection bias or healthy user effect), if
not properly adjusted for in observational studies, could lead
to an invalid estimate of vaccine effectiveness [6]. Moreover,
some studies gave evidence for the presence of selection bias
in most of the cohort studies assessing seasonal influenza
vaccine effectiveness in the elderly population [7,8].
Combining evidence from observational studies by using
standard methods of meta-analysis will compound this issue
[9]. For instance, the most recently conducted meta-analysis
assessing influenza vaccine effectiveness in elderly popula-
tion [10] found a high level of heterogeneity between
studies, which could be partly explained by unadjustedC BY-NC-ND license. 
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 After incorporating the effect of internal and
external biases, between-study heterogeneity
reduced considerably.
 In this case study, bias-adjustment method enables
us to identify the potential biases and to arrive at
more appropriate estimates, possibly at the cost
of less precision.
 Standard methods of meta-analysis do not take into
account the effects of biases in observational
studies. Bias-adjustment methods can be used to
quantify the effects of such biases in future meta-
analytic case studies.
sources of biases. It has been suggested that meta-analyses
of observational studies are prone to bias because they pool
the results from studies of differing quality (internal bias)
and relevance (external bias) [11].
Although biases could partly be addressed by using
quality scores through sensitivity analysis, it has been
shown that weighing the analysis by quality scores is inad-
equate [12,13], and sensitivity analysis is not applicable
when the number of included studies is low. Furthermore,
it might be possible to use meta-regression techniques to
investigate possible explanations of heterogeneity. Howev-
er, this is only a good strategy when a relatively large num-
ber of studies are included in the meta-analysis [4].
To resolve these limitations, a novel bias-adjustment
meta-analysis method has been proposed recently by Turner
et al. [14]. This method provides a technique to adjust for
internal and external biases through a process of eliciting
and incorporating expert opinion with the results of the
included studies in the meta-analysis. To estimate seasonal
influenza vaccine effectiveness in the community-dwelling
elderly against influenza and influenza-related outcomes,
we first conducted a conventional meta-analysis of cohort
studies (which are considered high in the hierarchy of obser-
vational studies). Secondly, we applied the bias-adjustment
method to quantify the potential biases in the conventional
meta-analysis. Finally, we compared the performance of
the 2 methodological approaches and discussed their advan-
tages and disadvantages.2. Methods
2.1. Conventional meta-analysis
2.1.1. Search strategy
We searched MEDLINE, EMBASE, and the Cochrane
library before September 2011 to identify cohort studies as-
sessing influenza vaccine effectiveness. The search strategyconsisted the following search terms: (‘‘Influenza Vacci-
nes’’[Mesh] OR ‘‘Influenza, Human/epidemiology’’[Mesh]
OR ‘‘Influenza Human/immunology’’[Mesh] OR ‘‘Influ-
enza, Human/mortality’’[Mesh] OR ‘‘Influenza, Human/
prevention and control’’[Mesh] OR ‘‘Influenza, Human/
transmission’’[Mesh] OR Influenza vaccine*[tiab] OR
(Influenza OR flu [tiab])) AND (Vaccine* OR immuni*
OR inocul* OR efficacy OR effectiveness [tiab]) AND
(old* OR age*OR elderly [tiab] OR older persons [tiab]
OR senior* [tiab]) AND (Clinical Trial [Mesh]
OR ‘‘Case-Control Studies’’[Mesh] OR ‘‘Cohort Studies’’
[Mesh] OR observational studies [tiab]). Only cohort
studies assessing seasonal inactivated influenza vaccine
effectiveness among community-dwelling elderly on
laboratory-confirmed influenza, influenza-like illness (ILI),
hospitalizations from influenza and/or pneumonia, and all-
cause mortality were included. In our study, laboratory-
confirmed influenza was defined as influenza confirmed by
viral isolation, or virus nucleic acid detected in a clinical
specimen, or when influenza-specific antibody response
was measured. ILI was defined as a sudden onset of high fe-
ver, cough (usually dry), headache, muscle and joint pain,
severe malaise (feeling unwell), sore throat, and runny nose
or a code R80 according to the International Classification of
Primary Care. Hospitalization from influenza and/or pneu-
monia was considered as an outcome when it was coded ac-
cording to the International Classification of Diseases (ICD)
version-10 as J12-18, J69.0, A48.1, J10.0, J10.1, J10.8,
J11.0, J11.8, according to ICD version-9 (ICD-9-CM) as
480e487 or when hospitalization because of pneumonia
was reported by the patient. All-cause death was recorded
when it was reported as such in the reviewed studies.
2.1.2. Data extraction
Two reviewers (MD and GG) independently extracted
data on the study population, characteristics of the partici-
pants, sample size, length of follow-up, inclusion and
exclusion criteria for vaccinated and unvaccinated individ-
uals, content and antigenic match of the administered vac-
cines, description of viral circulation, epidemic condition,
and outcomes. If information regarding the vaccine strains
and epidemic condition was not available in the studies, we
extracted this information from the World Health Organiza-
tion (WHO) Web site [15].
2.1.3. Statistical analyses
The extracted raw data on vaccination status and out-
comes from the cohort studies were entered into the Co-
chrane RevMan Software (version 5.2) [16]. Where
applicable, the adjusted odds ratios (ORs) were used to back
calculate the adjusted number of events by using the for-
mula r1adj z (ORadj)  (r2/n2)  n1, where r1adj is the
adjusted number of events in the intervention group, ORadj
is the adjusted effect size given in the original study, r2 is
the number of events in the control group, n2 is the total
number of participants in the control group, and n1 is the
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calculation assumes that the OR is equal to the risk ratio,
which is approximately true when outcome events are rare.
After combining the raw data, the pooled ORs and their
95% confidence intervals (95% CIs) were calculated using
the DerSimonian and Laird random-effects model [17].
We performed a subgroup analysis based on the
epidemic condition and vaccine matching. Vaccine match-
ing was defined as antigenic similarity between the vaccine
strains and the circulating viruses. If studies reported raw
data on the vaccination status and the outcomes for more
than 1 influenza season, we considered each influenza season
as a separate study, which had a separate dataset. To quantify
heterogeneity, the measure of inconsistency I2 (%) was
calculated as proposed by Higgins et al. [18], in which the
quantity I2 of 0% indicates no observed heterogeneity,
and larger values indicate increasing heterogeneity [18].
2.2. Application of bias-adjustment method
The bias-adjustment method developed by Turner et al.
[14] was applied to the same cohort studies included in
the conventional meta-analysis. The process of bias-
adjustment included several steps: (1) describing the target
setting of the meta-analysis, (2) defining an idealized
version of each individual study included in the meta-
analysis, (3) quantifying the effect of internal and external
biases in all the included cohort studies, (4) eliciting expert
opinion using bias elicitation scale and bias-checklist, and
(5) conducting a bias-adjusted meta-analysis.
2.2.1. Target setting
The target setting of our study was defined with respect
to: (1) the study population, which was community-
dwelling elderly aged 60 years and older; (2) the interven-
tion of the study, which was the seasonal influenza vaccine
recommended by WHO for a particular influenza season
when the study was conducted; (3) the control, which
was no administration of the seasonal influenza vaccine
during the period when the study was conducted; and (4)
the following outcomes: laboratory-confirmed influenza,
ILI, hospitalization from influenza and/or pneumonia, and
all-cause mortality during influenza season.
2.2.2. Idealized studies and internal and external biases
In the second step, we defined an idealized version of
each included study. The idealized study is an imagined
repeat of each study by means of a perfect design that could
eliminate all sources of internal biases [14]. We identify the
internal biases affecting each study by comparing the study
carried out against its idealized version. External biases can
be identified by comparing the idealized version of each
study with the target setting of the meta-analysis. For
example, if a study investigates the effect of vaccine in a
population aged 50 years and older, an external bias arises
because the target population of the idealized version ofthat study is older, that is 60 years and older. In a mini-
protocol available in the bias checklist (available on the
journal’s Web site), the idealized study should be defined
with respect to the population, which the researchers
planned to study (eg, community-dwelling elderly), their
planned comparison (eg, seasonal influenza vaccination
vs. no vaccination), and the outcome, which they planned
to measure. The idealized study with respect to different
outcomes was defined as follows: for the laboratory-
confirmed influenza outcome, the idealized study was
restricted to the patients who, according to European Cen-
ter for Disease Prevention and Control influenza case defi-
nition [19], had at least one of the following clinical forms:
ILI defined as sudden onset of symptoms, and at least one
of the 4 systematic symptoms: fever, malaise, headache, or
myalgia, and at least one of the 3 respiratory symptoms:
cough, sore throat, or shortness of breath, and at least one
of the laboratory criteria: isolation of the influenza virus
from a clinical specimen, or detection of the influenza virus
nucleic acid in a clinical specimen, or identification of the
influenza virus antigen by direct fluorescent antibody test in
a clinical specimen, or influenza-specific antibody
response. For the ILI outcome, the idealized study was
restricted to patients who had sudden onset symptoms, at
least one of the 4 previously mentioned systematic symp-
toms, at least one of the previously mentioned respiratory
symptoms, and a clinician judgment by a general practi-
tioner or a nurse that the illness was due to a respiratory
infection. For the hospitalization from influenza and/or
pneumonia outcome, the idealized study was restricted to
patients who had the diagnostic measurements of their dis-
ease such as laboratory tests and/or X-ray. For the all-cause
mortality outcome, no extra specification was required for
the outcome in the idealized study.
In this meta-analysis, internal biases were categorized
into 5 groups: (1) selection bias, which was defined as
baseline differences between the intervention and control
groups; (2) performance bias, which was suspected if sub-
jects did not receive their assigned intervention; (3) attri-
tion bias, which resulted from loss to follow-up and
missing data; (4) detection bias, which resulted from inac-
curate measurement of the outcomes; and (5) suspicion of
other biases defined as biases related to any other flaws
[14]. External biases were categorized into population
and outcome biases. Population bias resulted from the dif-
ference between age and health status of participants in
each study and the target population. Outcome bias
referred to the differences in the definition and timing of
the idealized study outcomes as compared with the target
setting outcomes [14]. Bias checklists were completed by
2 assessors (MD and GG) based on the extracted informa-
tion on the presence of internal and external biases in each
included study (a completed bias checklist is available at
www.jclinepi.com). Before the bias elicitation meetings,
all assessors read the bias checklists and the original
articles.
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Five quantitatively trained assessors (EH, WH, GG,
MD trained in epidemiology, and RT trained in medical
statistics) were involved in the internal bias elicitation
meeting and 4 subject-matter assessors (EH, WH, GG,
and MD) were involved in the external bias elicitation
meeting. At the meetings, assessors discussed each indi-
vidual bias with respect to whether the magnitude of the
bias was independent of the magnitude of the intervention
effect (additive bias) or proportional to the magnitude of
the intervention effect (proportional bias). Assessors
agreed that the effects of the internal biases were indepen-
dent of the magnitude of the intervention effect and that
the effects of the external biases could change the magni-
tude of the intervention effect. Therefore, all internal
biases in this meta-analysis were considered to be addi-
tive, and all external biases were considered to be propor-
tional. For example, the internal bias that is caused by
inadequate adjustment for the potential confounders is in-
dependent of the magnitude of the vaccination effect (ad-
ditive bias), whereas the external bias that is caused by a
study conducted during non-epidemic influenza season is
proportional to the intervention effect because it underes-
timates the vaccination effect. After the group discussion,
each assessor independently provided their opinion on the
impact and uncertainty of each of the biases on the bias
elicitation scales. Biases were then assessed on a relative
risk scale using a 67% CI, such that the assessor assumed
that the bias was twice as likely to lie inside rather than
outside this range (Appendix Fig. 1 at www.jclinepi.
com) [14]. Assessors judged the severity of the biases
on bias elicitation scales as no bias (1), low (0.9e1), me-
dium (0.7e0.9), or high (less than 0.7) both, in favor of
the intervention and control [14].
2.2.4. Bias-adjusted meta-analysis
Using the bias elicitation scale, the internal biases and
external biases from each assessor were elicited and used
to calculate the means and variances of the total additive
and total proportional bias for each study. The individual
additive biases have been summed to find total additive
bias, and the individual proportional biases have been
multiplied to find total proportional bias. These data were
then used to adjust the study effect estimates and standard
errors. The results were pooled across assessors using the
median estimate and median standard deviation [20].
Finally, fully bias-adjusted results were combined across
studies using random effects meta-analysis. Data were
analyzed with R statistical package [21] using the code
adopted from Turner et al. [14].
2.2.5. Agreement among assessors
To assess the agreement between the assessors, we first
calculated the means and variances of the internal and
external biases for each assessor separately. Then, we con-
ducted a mixed-effects model on the calculated meanvalues, treating the assessors as fixed effect and studies as
random effects, and weighed the residuals with the recip-
rocal of the measured variances of the biases. Using the
variance components of the studies and residuals, the intra-
class correlation coefficient (ICC) [22,23] was calculated
with approximate 95% CIs using the F-distribution [24]
based on the Satterthwaite approach [25]. The ICC ex-
pressed as percentage can be interpreted as a measure of
agreement [22,23].3. Results
3.1. Systematic literature search
The systematic literature search resulted in 2,256 poten-
tially relevant articles. After removing the duplicates,
1,785 titles and abstracts were screened by 2 independent
reviewers (MD and GG). EH was consulted in case of
disagreement. Only 14 studies met the inclusion criteria
(Appendix Table 1 at www.jclinepi.com) to be included
in the meta-analysis (Fig. 1). These 14 studies resulted in
19 datasets because some studies reported on multiple
influenza seasons (Appendix Table 2 at www.jclinepi.
com). Ten datasets measured vaccine effectiveness during
epidemic years. In 15 datasets, vaccine strains had a good
match with the circulating viruses. Two studies reported
vaccine effectiveness against laboratory-confirmed influ-
enza [26,27], 4 studies against ILI [27e30], 8 studies
against hospitalization from influenza and/or pneumonia
[28,31e37], and 5 studies against all-cause mortality
[28,30,37e39].3.2. Conventional meta-analysis
Pooling the data from the 2 studies that reported effec-
tiveness against laboratory-confirmed influenza showed that
seasonal influenza vaccine was not statistically significantly
effective (OR, 0.18; 95% CI: 0.01, 3.00). The study con-
ducted during an epidemic season [26] showed that a
well-matched influenza vaccine prevented laboratory-
confirmed influenza (OR, 0.05; 95% CI: 0.01, 0.35),
although this was not the case during a non-epidemic sea-
son (OR, 0.64; 95% CI: 0.12, 3.31) [27] (Appendix Fig. 2
at www.jclinepi.com).
Influenza vaccination was associated with a reduction of
ILI (OR, 0.55; 95% CI: 0.39, 0.78). The study conducted
during an epidemic season showed that influenza vaccine
was effective against ILI even when the vaccine strains
did not match the circulating viruses (OR, 0.39; 95% CI:
0.21, 0.74) [28]. The studies conducted during non-
epidemic seasons with a good vaccine match also demon-
strated a preventive effect (OR, 0.55; 95% CI: 0.33, 0.92)
[27,30]. The study conducted during a non-epidemic
season and with poor vaccine match did not show a
statistically significant reduction on the outcome (OR,
Fig. 1. Flowchart of the eligible cohort studies for inclusion in the meta-analysis.
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jclinepi.com).
Influenza vaccination was associated with a reduction
in hospitalization from influenza and/or pneumonia (OR,
0.67; 95% CI: 0.57, 0.77) (Table 3). The analysis of 6
datasets conducted in epidemic years showed a significant
reduction in hospitalization from influenza and/or
pneumonia in years with good vaccine match (OR, 0.70;
95% CI: 0.58, 0.84), and in years with poor vaccine match
(OR, 0.58; 95% CI: 0.42, 0.79). Four datasets from
non-epidemic years with good vaccine match demon-
strated a reduction in the outcome as well (OR, 0.51;
95% CI: 0.39, 0.67), whereas no reduction was observed
when there was a poor vaccine match (OR, 1.11; 95%
CI: 0.76, 1.60) [33] (Appendix Fig. 4 at www.jclinepi.
com).
Influenza vaccination was significantly effective in
reducing all-cause mortality (OR, 0.51; 95% CI: 0.40,
0.65). The analysis conducted during epidemic seasons
when vaccine strains were well matched with circulating vi-
ruses [37,38] showed a preventive effect (OR, 0.51; 95%
CI: 0.47, 0.54), whereas no such effect was observed when
the vaccine strains and circulating viruses did not match
(OR, 3.41; 95% CI: 0.77, 15.03) [28]. Vaccine did not show
statistically significant effectiveness against all-cause mor-
tality during a non-epidemic season when there was a good
match between the vaccine strains and the circulating vi-
ruses (OR, 0.50; 95% CI: 0.22, 1.13) [30,39] (Appendix
Fig. 5 at www.jclinepi.com). For all the outcomes exceptILI, the level of between-study heterogeneity was signifi-
cantly high (Table 3).3.3. Bias-adjusted meta-analysis
3.3.1. Biases identified
Appendix Table 3 (at www.jclinepi.com) summarizes
the suspected internal biases affecting the 14 included
studies in the meta-analysis. Selection bias was judged to
affect all the included studies. Different baseline character-
istics in the intervention and control group that is confound-
ing by indication, unclear inclusion and exclusion criteria,
and inadequate adjustment for potential confounders were
the most common reasons for the presence of selection
bias. Although the study effect estimates in 7 studies
[28,30,33,34,36e38] were partially adjusted for some con-
founders, in most of the studies the relevant confounders
such as health status and vaccine history have not been ad-
dressed. Detection bias was suspected in the studies that did
not use appropriate laboratory tests to confirm influenza
cases and in the studies that used self-reports to obtain in-
formation regarding ILI [26e30]. In these studies, symp-
tomatic patients not consulting the clinics were probably
not further tested for laboratory-confirmed influenza diag-
nosis. Furthermore, detection bias was suspected in the
studies that did not use objective measures such as labora-
tory test and/or X-ray to confirm the hospitalization from
influenza and/or pneumonia [28,31e37]. Other bias was
suspected in the study where some patients had a history
Table 1. Potential external biases identified in the studies
Study Population biasa (patients age) Outcome bias
Christenson et al. [31] 65 years and older
Christenson et al. [32] 65 years and older Study conducted during non-epidemic year
Fleming et al. [38] 55 years and older
Hara et al. [28] 65e79 years old Vaccine did not match circulating viruses
Kawai et al. [27] 65e104 years old Study conducted during non-epidemic year
Manzoli et al. [33] 65 years and older Study conducted during non-epidemic year, vaccine did not match circulating viruses
Nichol et al. [34] 65 years and older Study conducted during non-epidemic year (Nichol 1994 (a)), vaccine did not match
circulating viruses (Nichol 1994 (c))
Nichol et al. [35] 65 years and older
Nichol et al. [37] 65 years and older
Nicholson et al. [26] 60e90 years old
Ozasa et al. [29] 65 years and older Study conducted during non-epidemic year
Shapiro et al. [39] 65 years and older Study conducted during non-epidemic year
Voordouw et al. [30] 65 years and older Study conducted during non-epidemic year
Wang et al. [36] 65 years and older Study conducted in midseason period
a The target population of the meta-analysis was community-dwelling elderly aged 60 years and older.
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agreed that this bias could overestimate the effect of influ-
enza vaccination. Moreover, other bias was suspected in the
study where there was an overlap between the inoculation
period (eg, October 1, 2003 to December 31, 2003) and sur-
vey period (eg, December 1, 2003 to March 31, 2004) [28].
Assessors agreed that these biases could underestimate the
effect of the vaccination.
Population bias was suspected to affect all the included
studies because of the differences between the age of the
study population in the included studies and the population
in the defined target setting of the meta-analysis (Table 1).
For example, in a study conducted by Fleming et al. [38],Table 2. Geometric averages of the internal and external biases and relative
meta-analysis
Study
Influenza ILI
Internal bias External bias Internal bias Ext
Christenson et al. [31]
Christenson et al.(a) [32]
Christenson et al.(b) [32]
Christenson et al.(c) [32]
Fleming et al. [38]
Hara et al. [28] 0.84 (50.1) 0.8
Kawai et al. [27] 0.98 (69.6) 0.86 (17.2) 1.05 (41.4) 0.8
Manzoli et al. [33]
Nichol et al.(a) [34]
Nichol et al.(b) [34]
Nichol et al.(c) [34]
Nichol et al. [35]
Nichol et al.(a) [37]
Nichol et al.(b) [37]
Nicholson et al. [26] 0.70 (51.8) 0.98 (23.2)
Ozasa et al. [29] 0.99 (85.3) 1.1
Shapiro et al. [39]
Voordouw et al. [30] 0.78 (68.2) 0.9
Wang et al. [36]
Abbreviation: ILI, influenza-like illness.the influenza vaccine effectiveness was assessed among pa-
tients aged 55 years and older rather than the target age
range of 60 years and older. All assessors agreed that this
bias could make the intervention appear more effective
because the immune response to the vaccine reduces with
age and therefore, the vaccine would appear more effective
in younger age than in older age. Outcome bias was ex-
pected in the studies conducted during the non-epidemic
influenza seasons [32,27,33,34a,29,39,30] or when the vac-
cines did not match the circulating viruses [28,33,34c].
Furthermore, outcome bias was suspected in a study in
which the patient recruitment (January through June
2001) started 1 month after the peak of influenza seasonstandard deviations for each outcome in the included studies in the
Outcome
Hospitalization All-cause mortality
ernal bias Internal bias External bias Internal bias External bias
0.81 (40.6) 0.96 (6.0)
0.83 (49.2) 0.96 (6.0)
0.83 (49.2) 0.96 (6.0)
0.83 (49.2) 0.96 (6.0)
0.95 (28.4) 1.05 (6.4)
1 (23.8) 0.84 (50.1) 0.81 (23.8) 0.89 (43.1) 0.81 (23.4)
6 (17.2)
0.93 (50.5) 0.78 (24.1)
0.92 (32.2) 1.16 (21.9)
0.92 (32.2) 1.21 (19.5)
0.92 (32.2) 1.01 (26.8)
0.92 (32.2) 1.21 (19.5)
0.92 (32.2) 1.21 (19.5) 0.92 (31.2) 1.21 (19.5)
0.92 (32.2) 1.21 (19.5) 0.92 (31.2) 1.21 (19.5)
5 (34.6)
0.82 (58.6) 0.75 (25.2)
2 (8.1) 0.92 (48.3) 0.92 (8.5)
0.78 (72.7) 0.96 (56.0)
Table 3. Pooled odds ratios from conventional meta-analysis, meta-analyses adjusted for internal biases and meta-analyses adjusted for internal and
external biases
Outcome
Number of
studies per
outcome
Pooled OR (CI)
from conventional
meta-analyses
Test for
heterogeneity
P-value
Pooled OR (CI) from
meta-analyses adjusted
for internal biases
Test for
heterogeneity
P-value
Pooled OR (CI) from
meta-analyses adjusted
for internal and
external biases
Test for
heterogeneity
P-value
Influenza 2 0.18 (0.01, 3.00) I2 5 78%
P 5 0.03
0.22 (0.02, 2.13) I2 5 53%
P 5 0.14
0.23 (0.03, 2.04) I2 5 35%
P 5 0.21
ILI 4 0.55 (0.39, 0.78) I2 5 6%
P 5 0.36
0.63 (0.35, 1.15) I2 5 0%
P 5 0.87
0.64 (0.32, 1.29) I2 5 0%
P 5 0.87
Hospitalization from
influenza and/or
pneumonia
8 0.67 (0.57, 0.77) I2 5 82%
P ! 0.00001
0.71 (0.57, 0.87) I2 5 0%
P 5 0.96
0.75 (0.60, 0.94) I2 5 0%
P 5 0.99
All-cause mortality 5 0.51(0.40, 0.65) I2 5 91%
P ! 0.0001
0.61 (0.42, 0.90) I2 5 20%
P 5 0.29
0.64 (0.44, 0.92) I2 5 4%
P 5 0.39
Abbreviations: CI, confidence interval; OR, odds ratio; ILI, influenza-like illness.
740 M. Darvishian et al. / Journal of Clinical Epidemiology 67 (2014) 734e744(December to March 2001) [36]. Assessors expected that
these biases would reduce the effect of the intervention.
Because in the majority of the included studies, one dose
of the trivalent seasonal influenza vaccine recommended by
WHO for each influenza season was administered, the
possible variation among studies in the dose and delivery
of the influenza vaccine was regarded as diversity that
would arise in practice and was not treated as bias.
3.3.2. Bias assessment
To illustrate the magnitude and direction of the biases,
Table 2 represents the averages and the relative standard de-
viations of the total internal and total external biases (over
assessors) for all outcomes and all studies. Most of the bias
averages were smaller than one, meaning that assessors
believed that the study effect sizes were overestimated
because of likely presence of biases. On the other hand,
bias averages larger than one indicate that the assessors
believed that the study effect sizes were underestimated
because of the biases. For instance, in the conventional
meta-analysis, the measured OR for the study by Christen-
son et al. [31] for the outcome hospitalization from influ-
enza and/or pneumonia was 0.89 (95% CI: 0.80, 0.99).
After adjusting for the average of the total internal and
external bias, the OR shifted toward no effect OR of 1.11
(95% CI: 0.48, 2.58).
3.3.3. An example of the bias-adjustment process
To explain the bias-adjustment process, we will illustrate
it for the study by Wang et al. [36] (the completed bias
checklists and bias elicitation form is available on the jour-
nal’s Web site). The same results for the other studies can
be provided to readers on request. According to the article,
the influenza vaccination coverage for high-risk and low-
risk elderly was 58% and 29%, respectively, and study sub-
jects were relatively younger in the intervention group and
they had more underlying diseases compared with the con-
trol group. Moreover, although the study effect estimate
was partly adjusted for some confounders (age, sex, risk
status, and vaccination status), other important confoundingfactors (eg, previous vaccination history and health status)
were not addressed. In the bias-elicitation meeting asses-
sors agreed that differences between the baseline character-
istics of the intervention and control group and inadequate
adjustment for confounders could lead to selection bias.
Moreover, performance bias was suspected by all assessors
because it was not clear how the vaccination status was as-
certained. Because the article reported the attrition of 883
vaccinated elderly because of death or moving out of the
county, attrition bias due to loss to follow up was also
suspected.
Population bias was identified because of the differences
between the target age of the participants in the study
(65 years) and the target age of the meta-analysis
(60 years). Outcome bias was suspected because the pa-
tient recruitment (January through June 2001) started
1 month after the peak of the influenza season (December
to March 2001). Fig. 2A and B present the 67% ranges eli-
cited from the assessors AeE and AeD for internal and
external biases respectively. In total, there was a general de-
gree of consistency across the assessors on the internal and
external biases.
3.3.4. Agreement between the assessors
The agreement among the assessors for the outcome
hospitalization from influenza and/or pneumonia for inter-
nal and external biases was 61% (95% CI: 18, 82) for the
selection bias, 54% (95% CI: 25, 73) for the performance
bias, 37% (95% CI: 11, 61) for the detection bias, 78%
(95% CI: 50, 90) for the attrition bias, 7% (95% CI: 0.01,
30) for the population bias, and 18% (95% CI: 0.02, 57)
for the outcome bias. Fig. 3 presents an example of the
67% range for selection bias elicited by one assessor in
the study by Wang et al. [36].
3.3.5. Bias-adjusted meta-analysis: comparison of the
results
Pooled ORs from conventional meta-analysis, meta-
analyses adjusted for internal biases and meta-analyses
adjusted for internal and external bias are presented in
Fig. 2. (A) Internal biases in the study by Wang et al. [36]; 67% ranges elicited from assessors AeE, with means and 67% ranges for the total
internal bias. (B) External biases in the study by Wang et al. [36]; 67% ranges elicited from assessors AeD, with means and 67% ranges for
the total external bias.
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and external biases, the pooled OR for the outcome
laboratory-confirmed influenza increased to 0.23 (95%
CI: 0.03, 2.04) and the level of heterogeneity reduced
(I2 5 35%, P 5 0.21 vs. I2 5 78%, P 5 0.03 and
t2 5 0.87 vs. t2 5 3.21) (Appendix Fig. 6 at www.
jclinepi.com).
In the bias-adjusted meta-analysis of the 4 studies that re-
ported effectiveness as reduction of ILI, influenza vaccine
did not show statistically significant effectiveness against
ILI (OR, 0.64; 95% CI: 0.32, 1.29). After bias adjustment,
all studies point estimates shifted toward no effect, and their
CIs widened. Moreover, the relative weight given to each
study in the meta-analysis changed. For example, the study
by Kawai et al. [27] received 14% of the weight in the con-
ventional meta-analysis, although it received 29% of the
weight in the bias-adjusted meta-analysis because the biases
were judged to be smaller in this study as compared with the
other studies (Appendix Fig. 7 at www.jclinepi.com).
Pooling bias-adjusted point estimates from 13 datasets
showed that influenza vaccine was significantly associated
with a reduction in hospitalization from influenza and/or
pneumonia (OR, 0.75; 95% CI: 0.60, 0.94) with noFig. 3. Elicited 67% range for the selection bias byevidence of between-study heterogeneity (I2 5 0%,
P 5 0.99). Furthermore, the CI widened reflecting the un-
certainty because of the biases. After incorporating the ef-
fect of potential biases, the pooled estimate of the subgroup
analysis of studies conducted during the non-epidemic sea-
son when the vaccine matched the circulating virus was no
longer statistically significant (OR, 0.65; 95% CI: 0.39,
1.09) (Appendix Fig. 8 at www.jclinepi.com).
The bias-adjusted meta-analysis of 6 datasets from 5
studies showed that influenza vaccine was significantly
effective in preventing all-cause mortality in community-
dwelling elderly. After adjusting for the internal and
external biases, the pooled OR increased to 0.64 (95%
CI: 0.44, 0.92), the CI widened, and the between-study het-
erogeneity reduced (I2 5 4%, P 5 0.39 vs. I2 5 91%,
P 5 0.01 and t2 5 0.01 vs. t2 5 0.06). Moreover, in the
bias-adjusted meta-analysis datasets judged to be affected
by smaller biases with less uncertainty in their magnitude
[37,38] tended to have more weight in the meta-analysis
although datasets judged to be affected by greater biases
or more uncertain biases tended to have less weight
[28,30,39]. The subgroup analysis during the epidemic
years when vaccine matched the circulating virus showedone assessor in the study by Wang et al. [36].
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0.60; 95% CI: 0.41, 0.89) (Appendix Fig. 9 at www.
jclinepi.com).4. Discussion
In this article, we assessed the seasonal influenza vac-
cine effectiveness among community-dwelling elderly by
using 2 different meta-analyses techniques. The results of
the conventional meta-analysis showed that seasonal influ-
enza vaccine was effective in preventing ILI, hospitaliza-
tion from influenza and/or pneumonia, and all-cause
mortality among individuals aged 60 years and older living
in the community. Although the estimates pointed toward
effectiveness, the reduction in laboratory-confirmed influ-
enza was not statistically significant. We further found a
high level of heterogeneity between the studies, which
partly could be explained by failure of the conventional
methods to address the potential biases (eg, inadequate
adjustment for confounders) in the included studies [40].
In the next step, we therefore applied a recently
developed bias-adjustment approach to the conventional
meta-analysis [14]. In the bias-adjusted meta-analysis, the
potential biases in the included studies were addressed
through several steps: defining a target question, describing
an idealized version of each study, completing the bias-
checklist to identify potential biases, eliciting the bias
ranges, and performing a bias-adjusted meta-analysis. After
incorporating large amounts of uncertainty due to biases,
influenza vaccine showed statistically significantly effec-
tiveness in preventing hospitalization from influenza and/
or pneumonia and all-cause mortality. However, the vaccine
did not show statistically significant effectiveness against
ILI, which was previously observed in the conventional
meta-analysis. Compared with the conventional meta-
analysis, the pooled effect estimates for all the outcomes
moved slightly toward no effect with the largest relative
difference between unadjusted and adjusted ORs for
laboratory-confirmed influenza outcome (OR 0.18 vs.
0.23). Furthermore, the incorporated uncertainty because
of the size of the biases increased the within study error
which consequently widened the CIs and reduced the high
level of between-study heterogeneity [14]. Bias adjustment
also increased the relative weight of the studies with higher
quality as compared with the studies with lower quality. In
contrast to the conventional meta-analysis, the bias-
adjustment method enabled us to interpret the results when
also considering potential biases in the included studies.
There are several limitations for the bias-adjusted
approach we used. Firstly, despite all the efforts to address
the internal and external biases and to reduce the level of
heterogeneity, the vaccine effectiveness for a non-specific
outcome (all-cause mortality) was still unrealistically high
[7]. Secondly, although the assessors were chosen based
on their expertise, it is possible that other experts would
generate different results. In fact the degree of agreementbetween the assessors for some biases, that is population
bias and outcome bias, was low, and we believe that
increasing the number of assessors could improve the eli-
cited bias estimates and the generalizability of the results.
To further improve the method of bias-adjustment, it would
be desirable to incorporate empirical evidence on biases
from meta-epidemiological studies [41] in addition to
expert opinion [14]; however, empirical evidence is very
unlikely to become available for external biases, which
are specific to the target setting. Moreover, because the true
magnitude of the biases remains unknown, the level of un-
certainty given by assessors for some biases (eg, selection
bias) is very high, which could lead to very wide CIs. How-
ever, in our opinion, compared with the conventional meta-
analysis, the effect sizes are probably more appropriate
after taking into account the effect of biases. Finally the
bias-adjustment technique is a time-consuming process
[14]. Completing bias-adjustment checklists by one
assessor takes at least 2 hours. Based on our experience,
the bias elicitation process for each study took at least
30 minutes. Depending on the number of included studies
in the meta-analysis and outcomes of interest, this process
might take even longer.
4.1. Suggestions for future research
In this particular case study, bias-adjustment method
could reduce heterogeneity between the studies of seasonal
influenza vaccine effectiveness. This evidence may suggest
a considerable effect of biases in these non-randomized
studies. Selection bias, that is confounding by indication
and unclear inclusion and exclusion criteria, was the main
source of bias in the studies assessing influenza vaccine
effectiveness in the community-dwelling elderly. Adequate
adjustment for health (co-morbidity) status, history of
influenza or ILI, and history of previous influenza vaccina-
tion could reduce the selection bias [42]. To avoid detec-
tion bias, more information regarding the outcome
measures (eg, types of diagnostic tests to confirm the
outcome) should be provided. In the absence of random-
ized trials, further similar case studies using bias-
adjustment techniques or similar methods need to be used
to provide more consistent estimates of the influenza vac-
cine effectiveness [43].5. Conclusion
In this case study, the bias-adjustment method allowed
us to identify the potential internal and external biases in
the included studies. When the heterogeneity was reduced,
influenza vaccination of individuals aged 60 years and older
living in the community, showed statistically significant
effectiveness against hospitalization from influenza and/or
pneumonia and all-cause mortality, but not against influ-
enza and ILI. Under the assumption that the potential biases
on average were identified by assessors, we judge
743M. Darvishian et al. / Journal of Clinical Epidemiology 67 (2014) 734e744bias-adjustment method provides more appropriate effect
sizes for hospitalization from influenza and/or pneumonia
and all-cause mortality. Although the method provides a
tool to adjust for potential biases, it could be further
improved by increasing the number of assessors and incor-
porating empirical evidence on biases in the future studies,
if this becomes available. Moreover, more case studies are
needed to further evaluate this new method.Acknowledgments
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